logo

For the Inventor, By the Inventor

King of Prussia, PA, United States of America

Vicuron Pharmaceuticals Inc.


USPTO Granted Patents = 23

% Expired Patents = 39.1



Trademarks = 1

Forward Citations = 80

Loading Chart...
Loading Chart...

49 inventors (with patents filed for the assignee):

goldMedal Jason G Lewis (7 out of 7 patents)

silverMedal Martin Stogniew (6 out of 49 patents)

bronzeMedal Dinesh Vinoobhai Patel (6 out of 60 patents)

4.  Zhengyu Yuan (5 out of 10 patents)

5.  Enrico Selva (5 out of 27 patents)

6.  Daniele Losi (5 out of 6 patents)

7.  Mikhail Fedorovich Gordeev (4 out of 27 patents)

8.  Flavia Marinelli (4 out of 6 patents)

9.  Ameriga Lazzarini (4 out of 5 patents)

10.  Gianpaolo Candiani (4 out of 5 patents)

11.  Jeffrey William Jacobs (4 out of 43 patents)

12.  Rakesh K Jain (3 out of 34 patents)

13.  Sampath Kumar Anandan (3 out of 12 patents)

14.  Romeo Ciabatti (3 out of 29 patents)

15.  Marco Cavaleri (3 out of 4 patents)


23 patents:

1. 8143212 - Dalbavancin compositions for treatment of bacterial infections (2012-03-27),
2. 8007789 - Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof (2011-08-30),
3. 7763751 - Hydroxylamine derivatives (2010-07-27),
4. 7615635 - N-formyl hydroxylamines (2009-11-10),
5. 7612059 - Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use (2009-11-03),
6. 7407654 - Antibiotics GE 81112 factors A,B,B1, pharmaceutically acceptable salts and compositions, and use thereof (2008-08-05),
7. 7351687 - Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof (2008-04-01),
8. 7319088 - Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof (2008-01-15),
9. 7256177 - Lincomycin derivatives possessing antibacterial activity (2007-08-14),
10. 7199106 - Lincomycin derivatives possessing antimicrobial activity (2007-04-03),
11. 7199105 - Lincomycin derivatives possessing antibacterial activity (2007-04-03),
12. 7198796 - Antifungal parenteral products (2007-04-03),
13. 7169890 - Process for the production of ramoplanin-like amide derivatives (2007-01-30),
14. 7164011 - Lincomycin derivatives possessing antibacterial activity (2007-01-16),
15. 7119061 - Dalbavancin compositions for treatment of bacterial infections (2006-10-10),
Company Overview
Vicuron Pharmaceuticals Inc. is a biopharmaceutical company based in King of Prussia, Pennsylvania, specializing in the development of innovative therapies for serious infections. The company focuses on advancing novel antibiotics and antifungal agents to address the growing challenge of antimicrobial resistance. With a commitment to improving patient outcomes, Vicuron leverages cutting-edge research and technology to create effective solutions in the field of infectious diseases, contributing to global health advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#7 in King of Prussia, PA

#526 in Pennsylvania

#14,428 in US

#27,685 in the World

King of Prussia, PA (US)
King of Prussia, PA, United States of America

Vicuron Pharmaceuticals Inc.

Forward Citations = 80

49 inventors:

goldMedal Jason G Lewis (7 out of 7 patents)

silverMedal Martin Stogniew (6 out of 49 patents)

bronzeMedal Dinesh Vinoobhai Patel (6 out of 60 patents)

4.  Zhengyu Yuan (5 out of 10 patents)

5.  Enrico Selva (5 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vicuron Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/vicuron-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…